Stockreport

Immix Biopharma Announces Pricing of $15 Million Public Offering of Common Stock [Yahoo! Finance]

Immix Biopharma, Inc.  (IMMX) 
PDF biopharmaceutical company pioneering personalized therapies for oncology and immunology, today announced that it has priced an underwritten public offering of 5,535,055 [Read more]